Aeon Life raises 7.5 million francs

(CONNECT) Aeon Life, a platform of MRI Health Holding AG, has raised around 7.5 million Swiss francs in a seed financing round. The round was led by the London-based venture fund Concentric, the Winterthur-based healthtech announced in a press release. Aeon Life intends to use the funds to set up new locations in Switzerland, Germany and the UK. The opening of more than ten new locations is planned for the coming months.

The start-up has developed a platform for preventive medicine. For its full-body check-ups, Aeon Life combines magnetic resonance imaging (MRI), genetic analysis and blood tests with artificial intelligence (AI). AI is used to detect anomalies on MRI images and to cross-validate the MRI, blood and gene data. The AI also creates a personalized risk profile from each full-body check-up. The funds from the seed financing will be used to further improve the AI platform.

“We are redefining prevention - moving away from reactive checks towards proactive, personalized health management,” Tim Seithe, co-founder and CEO of Aeon Life, is quoted as saying in the press release. The focus here is on avoiding false-positive findings. A number of health insurance companies already cover up to 75 percent of the costs of Aeon Life's full-body check-ups, depending on the policy. For Alex Stroud, Principal at Concentric, Aeon offers “the most medically robust prevention product on the market today”. ce/hs